CochLear Net Cash Flow 2023-2024 | CHEOY
CochLear annual/quarterly net cash flow history and growth rate from 2023 to 2024. Net cash flow can be defined as the total change in cash for the company over the given period.
- CochLear net cash flow for the quarter ending June 30, 2024 was $-0.027B, a 0% increase year-over-year.
- CochLear net cash flow for the twelve months ending June 30, 2024 was $-0.063B, a 0% increase year-over-year.
- CochLear annual net cash flow for 2024 was $-0.027B, a 44.69% decline from 2023.
- CochLear annual net cash flow for 2023 was $-0.05B, a 447.62% decline from 2022.
- CochLear annual net cash flow for 2022 was $0.014B, a 0% decline from 2021.
| CochLear Annual Net Cash Flow (Millions of US $) |
|
|---|---|
| 2024 | $-27 |
| 2023 | $-50 |
| 2022 | $14 |
| 2021 | $N/A |
| 2020 | $N/A |
| 2019 | $N/A |
| 2018 | $N/A |
| 2017 | $N/A |
| 2016 | $N/A |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $11.134B | $1.488B |
| Cochlear Limited provides implantable hearing solutions principally in the Americas, Europe, the Middle East, Africa and the Asia Pacific. The company offers cochlear implants, including Nucleus 7 and Kanso sound processors; Carina middle-ear implants and accessories and Baha bone conduction implants. Cochlear Limited is based in Sydney, Australia. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $145.009B | 27.20 |
| Elevance Health (ELV) | United States | $86.741B | 11.19 |
| CVS Health (CVS) | United States | $81.290B | 10.10 |
| Cencora (COR) | United States | $55.092B | 19.17 |
| DiDi Global (DIDIY) | China | $23.485B | 35.64 |
| Natera (NTRA) | United States | $22.560B | 0.00 |
| BioMerieux (BMXMF) | France | $16.856B | 0.00 |
| Solventum (SOLV) | United States | $13.071B | 13.84 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.026B | 0.00 |
| ICON (ICLR) | Ireland | $11.688B | 10.87 |
| Revvity (RVTY) | United States | $11.345B | 19.52 |
| Doximity (DOCS) | United States | $10.995B | 50.90 |
| Viatris (VTRS) | United States | $10.610B | 3.65 |
| Avantor (AVTR) | United States | $9.329B | 13.55 |
| HealthEquity (HQY) | United States | $9.272B | 40.61 |
| Medpace Holdings (MEDP) | United States | $8.792B | 23.35 |
| Sonic Healthcare (SKHHY) | Australia | $8.450B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.416B | 14.53 |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| Bausch + Lomb (BLCO) | Canada | $4.450B | 26.21 |
| BrightSpring Health Services (BTSG) | United States | $3.875B | 35.87 |
| Sotera Health (SHC) | United States | $3.491B | 19.84 |
| Surgery Partners (SGRY) | United States | $2.989B | 38.87 |
| Alignment Healthcare (ALHC) | United States | $2.898B | 0.00 |
| Concentras Parent (CON) | United States | $2.816B | 16.27 |
| Organon (OGN) | United States | $2.610B | 2.77 |
| GeneDx Holdings (WGS) | United States | $1.983B | 76.39 |
| Progyny (PGNY) | United States | $1.923B | 42.32 |
| Ardent Health Partners (ARDT) | United States | $1.920B | 8.18 |
| Premier (PINC) | United States | $1.884B | 14.30 |
| PACS (PACS) | United States | $1.629B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.622B | 32.43 |
| Teladoc Health (TDOC) | United States | $1.298B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.213B | 9.23 |
| Establishment Labs Holdings (ESTA) | $1.124B | 0.00 | |
| CareDx (CDNA) | United States | $1.105B | 17.26 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.011B | 0.00 |
| Agilon Health (AGL) | United States | $0.944B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.843B | 7.89 |
| QDM (QDMI) | Hong Kong, SAR China | $0.752B | 0.00 |
| Nutex Health (NUTX) | United States | $0.651B | 9.85 |
| Embecta (EMBC) | United States | $0.592B | 3.99 |
| LifeMD (LFMD) | United States | $0.553B | 0.00 |
| Enhabit (EHAB) | United States | $0.543B | 44.67 |
| InnovAge Holding (INNV) | United States | $0.514B | 0.00 |
| SBC Medicals (SBC) | United States | $0.495B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.474B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.470B | 10.58 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.445B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.258B | 0.00 |
| Oncology Institute (TOI) | United States | $0.237B | 0.00 |
| Beauty Health (SKIN) | United States | $0.202B | 0.00 |
| DocGo (DCGO) | United States | $0.156B | 25.50 |
| KindlyMD (KDLY) | United States | $0.150B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.104B | 0.00 |
| So-Young (SY) | China | $0.090B | 0.00 |
| OncoCyte (OCX) | United States | $0.079B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.075B | 0.00 |
| KindlyMD (NAKA) | United States | $0.070B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.060B | 0.00 |
| NeueHealth (NEUE) | United States | $0.060B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.057B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.056B | 0.00 |
| Biodesix (BDSX) | United States | $0.048B | 0.00 |
| ModivCare (MODV) | United States | $0.047B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.029B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.013B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.013B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.010B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.006B | 0.00 | |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |